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Abstract  
Background: Asthma, the main inflammatory chronic condition affecting the respiratory 
system, is characterized by hyperresponsiveness and reversible airway obstruction, 
recruitment of inflammatory cells and excessive production of mucus. Cytokines as 
biochemical messengers of immune cells, play an important role in the regulation of 
allergic inflammatory and infectious airway processes. Essential oils of plant origin are 
complex mixtures of volatile and semi volatile organic compounds that determine the 
specific aroma of plants and are categorized by their biological activities. 
Purpose: We reviewed whether essential oils and their bioactive compounds of plant 
origin could modulate cytokines’ immune responses and improve asthma therapy in 
experimental systems in vitro and in vivo.  
Methods: Electronic and manual search of articles in English available from inception 
up to November 2018 reporting the immunomodulatory activity of essential oils and 
their bioactive compounds for the management of asthma. We used PubMed, 
EMBASE, Scopus and Web of Science. Publications reporting preclinical experiments 
where cytokines were examined to evaluate the consequence of anti-asthmatic therapy 
were included.  
Results: 914 publications were identified and 13 were included in the systematic review. 
Four articles described the role of essential oils and their bioactive compounds on 
bronchial asthma using cell lines; nine in vivo studies evaluated the anti-inflammatory 
efficacy and immunomodulating effects of essential oil and their secondary metabolites 
on cytokines production and inflammatory responses. The most important 
immunopharmacological mechanisms reported were the regulation of cytokine 
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production, inhibition of reactive oxygen species accumulation, inactivation of 
eosinophil migration and remodeling of the airways and lung tissue, modulation of 
FOXP3 gene expression, regulation of inflammatory cells in the airways and decreasing 
inflammatory mediator expression levels.  
Conclusion: Plant derived essential oils and related active compounds have potential 
therapeutic activity for the treatment of asthma by modulating the release of pro-
inflammatory (TNF-α, IL-1, IL-8), Th17 (IL-17), anti-inflammatory (IL-10), Th1 (IFN-
γ, IL-2, IL-12) and Th2 (IL-4, IL-5, IL-6, IL-13) cytokines and the suppression of 
inflammatory cell accumulation. 
Keywords: Asthma, Allergy, Cytokines, Essential oil, Inflammation, 
Immunomodulatory 
 
 
 
Abbreviations: BALF, Bronchoalveolar Lavage Fluid; COPD, Chronic Obstructive 
Pulmonary Disease; DEP, Diesel Exhaust Particles; ELISA, Enzyme-Linked 
Immunosorbent Assay; OVA, Ovalbumin; PRISMA, Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses; qPCR, Quantitative Real‐ time Polymerase 
Chain Reaction; ROS, Reactive Oxygen Species;  
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Introduction 
     Asthma is a chronic inflammation of the airways characterized by the infiltration of 
inflammatory cells, inflammation, hyperresponsiveness and remodeling (Murdoch and 
Lloyd, 2010) that can be induced or exacerbated by exposure to environmental triggers 
(Hardy et al., 2015). Its symptoms include excessive production of mucus leading to 
airway obstruction (Doeing and Solway, 2013) and is often accompanied by infiltration 
of the airways by eosinophils, mast cells and lymphocytes, thickening of the bronchial 
walls, and hypertrophy/hyperplasia of airway smooth muscle (Cheng et al., 2018). 
     The prevalence of asthma has increased in recent decades and is currently one of the 
most common causes of respiratory morbidity in the world (Nunes et al., 2017), 
affecting individuals across the age spectrum (Tang et al., 2018). It is estimated that 
more than 300 million people worldwide have asthma (Nunes et al., 2017). 
Inflammation of the airways in asthma is associated with stimulation of T helper (Th) 2 
cell-derived immune responses and production of Interleukins (IL)-4, 5, and 13 (Ku et 
al., 2016) and other cytokines, such as IL-1 and 33, tumor necrosis factor alpha (TNF-α) 
and transforming growth factor beta (TGF-β), play a pivotal role in the pathophysiology 
of allergic reactions (Verheijden et al., 2016; Tettamanti et al., 2018). Recent 
experimental studies have shown that maintaining the Th1/Th2 immune balance could 
protect against asthma exacerbations (Rao et al., 2017) and several trials have aimed to 
enhance the inhibition of Th2 cell-derived cytokines such as IL-4 and 5 (Rivera et al., 
2011). 
      Herbal remedies are a popular form of complementary or alternative medicine for 
asthma and nearly 40% of asthmatics have used herbal remedies (Ernst, 1999). Essential 
oils extracted from plants are mixtures of volatile compounds, mainly mono- and 
sesquiterpenoids, phenylpropanoids containing hundreds of bioactive chemical 
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constituents. These oils have antifungal, acaricidal, antiviral and bactericidal properties 
and could have potential roles for the management asthma (Pina et al., 2018). Thanks to 
their volatility these oils can easily reach the upper and lower respiratory tract (Levy et 
al., 2018), where they could reduce IgE, IL-4, 5 and 13 levels and inflammatory cells 
(Horváth and Kamilla, 2015). This review examines in vitro and in vivo studies 
reporting the effect of essential oils and their bioactive compounds in anti-asthmatic 
activity, highlighting the specific cytokines immunomodulated. 
Materials and methods 
     The review was conducted following the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement (Moher et al., 2009). 
Search strategy 
    Peer reviewed publications in English were extracted from the PubMed, EMBASE, 
Scopus and Web of Science databases, restricted to Medical Subjects Headings Index 
(MeSH/DeCS) up to November 2018. The search used the keywords: "Essential oil", 
"Medicinal Plants", "Bio-active Compounds", “Cytokines", "Asthma", "Anti-asthmatic 
Effect", "Natural Products", "Inflammation", "Immunomodulatory" and "Immune 
Response". In addition, we reviewed the references listed in the articles selected to 
identify additional reports not included in the databases. 
Study selection 
     Two authors (GRG and ABSV) extracted and checked the titles and abstracts of the 
articles independently. Studies investigating the anti-asthmatic action of essential oils 
and bioactive compounds in preclinical models and discussing possible mechanisms of 
action through specific cytokine-mediated signaling pathways were included. We 
excluded human studies, review articles, meta-analyses, book chapters, conference 
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abstracts, editorials/letters, patents and case reports. Disagreements among the two 
authors were resolved by a third author (RQG) through discussion.  
Data extraction 
     Data were extracted and summarized in tables. Table 1 summarizes data of in vitro 
studies, including a) author’s name and publication year b) substances and their 
concentrations c) cytokines assessed d) components identified e) cell lines or strains 
used f) proposed mechanisms of biochemical results. Table 2 provides data on 
experimental studies, including a) author’s name and year b) experiment design c) 
substances and concentrations d) dose/route of administration/animal model e) 
outcomes f) biochemical mechanisms and results.  
Methodological quality and risk of bias 
     The methodological quality of the studies was assessed using standard checklists and 
mandatory statements of random allocation and concealment of treatment, compliance 
with welfare regulations, blinding of drug administration, evaluation of outcomes, 
depiction of animal losses and comprehensiveness of outcome data (Hooijmans et al., 
2014). The quality analysis was depicted using colors as suggested by Roskosk-Jr 
(2017). 
Data analysis 
     The data is presented as a narrative. Pooling statistics and meta-analysis were not 
used due to the heterogeneity of the studies. 
Results and discussion 
Search results 
     Figure 1 presents a flowchart of the search. Nine hundred and fourteen articles were 
identified (PubMed: 381, EMBASE: 99, Scopus: 228 and Web of Science: 206), 
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including 251 duplicates. Of these, 640 were excluded after screening the abstracts 
because they did not report cytokines, were case reports or review articles. Twenty-three 
publications were selected for full-text review and of these, thirteen, four in vitro and 
nine in vivo, met the eligibility criteria. 
Study characteristics and description 
     Four in vitro studies investigated the effect of plant-derived essential oils and their 
components against inflammatory airway disease in cell lines of bronchial asthma. A 
further nine in vivo studies assessed the essential oils and their components effect in 
mouse models of asthma characterized by eosinophil-dominant inflammation in actively 
sensitized mice. The chemical structures of the essential oil components are shown in 
Figures 2 and 3. Most of the studies used monoterpenes, sesquiterpene and triterpene 
alcohols (n = 6) and quinones (n = 2). Two studies used cyclic monoterpene and three 
used crude essential oils. Four studies originated from Japan, three from Taiwan, two 
each from USA and Iran and one each from Brazil and Germany.  
      In vitro experiments were performed in human bronchial epithelial (BEAS-2B), lung 
mucoepidermoid carcinoma (H292), lung carcinoma (A549), eosinophilic leukemia 
(HL-60 clone 15) and mouse splenocytes cell lines. Numerous experimental approaches 
were used in the in vitro studies, including the inhibition of eosinophil migration, 
cytokine assays, level of reactive oxygen species and determination of levels and 
expression of molecules in innate immune responses. The main finding of the in vivo 
studies is that mice strains, such as BALB/c, are suited for experimental protocols of 
asthmatic inflammatory reactions. BALB/c mice models have been used extensively in 
asthma-related inflammatory disease with identical airway responsiveness and bronchial 
inflammation with hyperproduction of Th2 cytokines to humans (Gueders et al., 2009). 
This model was recurrently reported in the in vivo studies included.  
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      Two experimental mouse models of allergic inflammation and asthmatic disorders 
have been used to describe the immunomodulation effect of essential oils and their 
components. These include the ovalbumin-sensitized airway inflammation and the 
Dermatophagoides farinae-induced airway hyperresponsiveness and eosinophilic 
infiltration. Several methods have been used to study changes in mouse models of 
asthma, including the assessment of airway responsiveness, leukocyte counts, 
proinflammatory and inflammatory mediators and markers, cytokine levels, antibody 
titres, lung resistance, histopathology and histomorphometric analyses, levels of 
immunostimulatory dependent signalling molecules and transcription factors.  
In vitro studies of cytokine responses to essential oil and constituents in asthmatic 
condition 
     In vitro studies investigating the systemic treatment of asthma with essential oils of 
ginger and bioactive compounds, such as limonene from Citrus junos, terpenoids from 
Zingiber officinale, carvacrol and thymol have used established cell lines models of 
asthmatic syndromes via regulating proinflammatory, Th1 and Th2 cytokines to 
enhance immune responses in experimental bronchial asthma (Table 1). Limonene from 
Citrus junos inhibits the diesel exhaust particles (DEP)-stimulated p38 mitogen 
activated protein kinase (MAPK) signaling pathway and modulates eotaxin-induced 
chemotaxis by inhibiting TNF-α, IL-1β, IL-8 and IL-10 (Hirota et al., 2010). In 
addition, monocyte chemoattractant protein (MCP)-1 production decreases, suggesting 
that limonene might decrease monocyte and eosinophil infiltration in the lungs. The 
bioactive constituents of essential oils of various plants may have potential therapeutic 
roles for the management of bronchial asthma through their role in controlling reactive 
oxygen species (ROS) production, inactivating eosinophil migration and ameliorating 
oxidative damage to the lung (Beck-Speier et al., 2005).  
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     Regarding the attenuation of airway inflammation, the increased number of 
inflammatory cells in the bronchioalveolar lavage fluid (BALF) of rats after 
lipopolysaccharide treatment is significantly reduced by a ginger extract (Aimbire et al., 
2007). Ginger volatile oils and their terpenoid compounds have anti-inflammatory and 
regulatory effects on lipopolysaccharide-stimulated BEAS-2B-induced IL-8 and TNF-α 
secretion and might be promising against inflammatory airway diseases (Podlogar and 
Verspohl, 2011). 
     Carvacrol or cymophenol is considered the foremost constituent of several plants 
including Zataria multiflora, that demonstrate beneficial properties on respiratory 
diseases, including asthma (Alavinezhad et al., 2017). It has been hypothesized that 
carvacrol from Carum copticum essential oil has relaxant effects on smooth muscles of 
guinea pig tracheal chains and bronchodilator effects (Boskabady et al., 2003). The 
immunologic feature of asthma is a balance shift from Th1 to Th2 (Jalali et al., 2013). 
The increased cytokine production of IL-4, -5 and -13 has been shown in BALF and 
airway biopsies of patients with mild or asymptomatic asthma (Walker et al., 1992). 
Th2 cytokines are required for the development of airway eosinophilia and to stimulate 
an inflammatory response that results in asthma (Ray and Cohn, 1999). Th1 inhibits 
Th2 responses through the secretion of INF-γ, IL-2 and TGF-β and thus the goal of 
asthma therapy should be the balance of Th1/Th2 (Randolph et al., 1999). Carvacrol 
potentiates anti-inflammatory reactions through the improved balance of Th1 (IFN‐ γ) 
and Th2 (IL-4) cytokine gene expression in splenocytes of sensitized mice. The immune 
modulatory effect of carvacrol is more effective than dexamethasone in sensitized mice 
splenocytes, indicating it has potential therapeutic value in allergy, autoimmunity and 
infection (Kianmehr et al., 2016).  
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     The major phenolic monoterpenoids found in genera Origanum and Thymus are 
carvacrol and thymol, the most abundant essential oil constituents of various plants 
(Alavinezhad et al., 2018). In in vitro T-cell models, carvacrol and thymol can affect 
transcriptional factors that regulate inflammation by reducing IL-2 and IFN-γ 
production (Gholijani et al., 2015, 2016). Carvacrol and thymol inhibit the effects of 
chitin on type-2 promoting cytokines IL-25 and IL-33 released in asthmatic conditions. 
Chitin is a component of the cell walls of fungi, crab, shrimp, insects and house dust 
mites which correlates with asthma (Koch et al., 2015). Previous reports have found 
increases in IL-25 and IL-33 or the receptors in mice lungs inflamed after chitin 
administration (Yasuda et al., 2012; Van Dyken et al., 2014). Moreover, IL-33 is 
involved in other pathological conditions, such as cardiovascular diseases, arthritis, 
infection, sepsis, atherosclerosis, neurological disorders, cancer and allergy (Pan et al., 
2018). The direct administration of chitin to airway epithelial cells is likely to contribute 
to allergic airway reactions and carvacrol and thymol may inhibit epithelial pro-
inflammatory cell responses to chitin by inhibiting type-2 promoting cytokine release 
and immune responses (Khosravi and Erle, 2016). 
In vivo studies of cytokine responses to essential oil and constituents in asthmatic 
condition  
     Thymoquinone reduces elevated levels of IL-4, 5 and 13 secretion and increases IL-
10 in ovalbumin (OVA)-sensitized and challenged mice (EI Gazzar et al., 2006). IL-4 is 
required for Th2 cell differentiation and isotype switching in B cells from IgM to IgE 
production (Kopf et al., 1993; Holgate, 2004), whereas, IL-5 and IL-13 regulate growth, 
differentiation, and survival of eosinophils (Domae et al., 2003). IL-13 promotes IgE 
isotype switching in B cells and mucus production by goblet cells in the airway mucosa 
(Zhu et al., 1999). Thymoquinone causes obstruction of lung tissue eosinophilia and 
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goblet cells hyperplasia which could be due to its intense action on Th2 cytokines and 
inflammatory cells in the airways.  
     EI Mezayen et al., (2006) reported that thymoquinone attenuates OVA-induced 
airway inflammation by inhibiting cyclooxygenase-2 (COX-2) expression and 
prostaglandin D2 production and IL-4, 5 and 13 levels. The inhibition of prostaglandin 
D2 synthesis plays an important role in modulating Th2 cytokine levels, lung 
eosinophilia, goblet cell hyperplasia and mucus hyperproduction in allergic airway 
inflammation (Larche et al., 2002; Herrick and Bottomly, 2003). Thymoquinone 
suppressed the immunologic and inflammatory responses induced by Th2 cytokines in a 
mouse model of airway inflammation and had anti-inflammatory effects in allergic lung 
responses. 
     Perilla oil diminished bronchoalveolar inflammation by decreasing the secretion of 
pro-inflammatory and Th1 cytokines into the local lung and airway tissues but failed to 
regulate the Th1/Th2 balance toward the Th1 pole in Th2-skewed allergic airway 
inflammation (Chang et al., 2008). Limonene treated mice had reduced IFN-γ, IL-5, IL-
13 and TGF-β levels and lower numbers of eosinophils in the lungs of 
Dermatophagoides farina-induced airway hyperresponsiveness asthma model (Hirota et 
al., 2012). IL-13 is linked to mucus hypersecretion by hyperplastic goblet cells that 
create airway mucus plugs, especially in peripheral airways of asthmatics (Li et al., 
2003). TGF-β is associated with the development of airway remodeling in asthma and 
correlates with thickening of the basement membrane (Matsukuara et al., 2010; Tian et 
al., 2011).  
      Lavender essential oil inhalation extinguishes eosinophils in BALF and lung tissue 
concomitantly with a decrease in IL-5 and IL-13 levels in bronchial tissue of 
experimental asthmatic mice (Ueno-Iio et al., 2014). Eosinophils play a key role in the 
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pathogenesis of bronchial asthma, while IL-5 plays a key role in the development and 
migration of eosinophils and correlates with the severity of eosinophilic inflammation 
(Sanderson, 1992). IL-13 remodels the infiltration of inflammatory cells into BALF and 
peri-bronchial and perivascular tissues (Zhou et al., 2012).   
     Farnesol, a sesquiterpene alcohol widely present in fruits, vegetables and essential 
oils (Duncan and Archer, 2008) restores IL-2. IL-4, IL-5, IL-10, IL-1β and TNF-α 
levels in distorted BALF due to OVA sensitization and challenge in asthmatic mice, 
suggesting it may have potential to modulate the Th1/Th2 balance in lungs (Ku and Lin, 
2015). Th2 cells are the major source of IL-10 production, although excessive IL-10 
secretion may inhibit the production of IL-1β and TNF-α (Iyer and Cheng, 2012). 
Farnesol supplementation ameliorates serum lipid profiles in OVA-sensitised and 
challenged mice and reduces increased non-specific IgE, IgA, IgM, and IgG levels after 
OVA sensitisation and challenge, suggesting that its supplementation regulates Th2 
cytokine ratios in BALF and reduces inflammation.  
     Zataria multiflora has a relaxant effect on tracheal responsiveness, bronchodilator 
and regulation of inflammatory mediators in OVA-sensitized guinea pigs (Boskabady et 
al., 2014) and a preventive effect on emphysema and pathological changes of the lung 
and systematic inflammation in guineas pigs’ models of chronic obstructive pulmonary 
disease (COPD) (Gholami Mahtaj et al., 2015). The extract of Zataria multiflora thymol 
as main constituent decreases pro-inflammatory cytokines (IL-4 and IL-17 and TGF-β) 
but increases anti-inflammatory (IFN-γ) cytokine and Forkhead box P3 (FOXP3) gene 
expression in splenocytes of asthmatic mice, suggesting a specific therapeutic effect in 
allergy, autoimmunity and infection potentiating Th1 and suppressing Th2 and Th17 
cells. (Kianmehr et al., 2017) 
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      The alcoholic monoterpenes citronellol, α-terpineol and carvacrol largely present in 
plants of the genus Cymbopogon, Eucalyptus and Origanum are used for the treatment 
of inflammatory diseases (Guimaraes et al., 2013). Citronellol, α-terpineol and carvacrol 
modulates eosinophil migration and decreases TNF-α levels in the mice pleural cavity 
after induction by OVA. These effects can be associated with the monoterpenes’ ability 
to inhibit important targets of inflammatory mediators and could be prospective 
candidates as drugs in the therapy of allergic inflammation and asthma.  
  Methodological quality/risk of bias 
       The methodological features of the in vivo studies are detailed in Figure 4. All 
papers selected reported the allocation sequence generation with random procedures. 
However; none of them reported blinding procedures. The animal experiments had a 
lack of blinding of the interventions allocated (performance bias) and outcome 
assessment (detection bias) (Fig. 5).  
Conclusions 
     This review assessed the anti-inflammatory and immune-modulating activities of 
essential oils and their bioactive compounds linked to cytokine expression and secretion 
in airway pathologic reactions, highlighting the immunoregulatory mechanisms 
enhancing cytokine responses, triggering of immune cells, orientate immune regulation 
and decreased inflammation associated with asthma. The pharmacology and 
pharmacokinetics of several plant-derived essential oils remain to be clearly established 
using cellular and animal models of asthma. 
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Figures legends 
 
 
Fig. 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) flow diagram of article search and selection included in this review. 
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Fig. 2. Chemical structures of essential oil constituents (I) 
 
 
 
Fig. 3. Chemical structures of essential oil constituents (II) 
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Fig. 4.  Analysis on methodological quality and results of studies. Blue and magenta 
bars represent the proportion of studies for which the item was or was not applicable. 
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Fig. 5.  Risk of bias level. Blue: Low; Magenta: High. 
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Table 1 In vitro studies of cytokine responses to essential oil and bioactive constituents 
in asthmatic condition 
Autho
rs, 
Year, 
Count
ry 
Substa
nce 
Concentra
tion 
Cell lines 
Objectiv
es 
 
Cytokine
s studied 
Assa
ys 
Improved 
Characteristi
cs 
Hirota 
et al., 
2010; 
Japan
 
Limone
ne from 
Citrus 
junos  
7.34 
mMol/L 
HL-60 clone 
15 cells 
(Human 
leukemia cell 
line) 
To 
investigat
e anti-
inflamma
tory 
effect of 
limonene 
on human 
eosinophi
lic 
leukemia  
Tumor 
necrosis 
factor 
alpha 
(TNF-α), 
interleuki
n 1 beta 
(IL-1), 
IL 
(interleuk
in)-8, IL-
10 
ELIS
A 
Limonene 
may have 
potential anti-
inflammatory 
efficacy 
against 
bronchial 
asthma by 
inhibiting 
cytokines 
production 
 
Podlog
ar and 
Verspo
hl 
2011; 
Germa
ny 
 
 
Ginger 
volatile 
oil 
(Zingib
er 
officina
le) 
 
 
0.1-1  
μg/mL 
 
BEAS-2B 
(Human 
bronchial 
epithelial cell 
line) 
 
Ginger 
volatile 
oil 
and its 
compoun
ds were 
tested 
against 
human 
bronchial 
epithelial 
cells 
 
IL-8 and 
TNF-α  
 
ELIS
A 
 
 
Ginger oil and 
its terpenoid 
compounds 
could be used 
as anti-
inflammatory 
drugs in 
respiratory 
infections 
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Kianm
ehr et 
al., 
2016;  
Iran 
 
 
 
Carvacr
ol 
 
75, 150 
and 300 
μg/mL 
 
Splenocytes 
 
Effects of 
carvacrol 
on 
cytokines 
genes 
expressio
n in 
splenocyt
es of 
asthmatic 
mice  
 
IL‐4, 
IFN‐γ, 
transform
ing 
growth 
factor 
beta 
(TGF‐β) 
and IL‐
17 
 
qPC
R 
 
 
Immunomodu
latory effect 
of carvacrol 
indicating 
increased 
IFN‐γ and 
FOXP3 but 
decreased IL‐
4, TGF‐β, and 
IL‐17 
expression 
Autho
rs, 
Year, 
Count
ry 
Substa
nce 
Concentra
tion 
Cell lines 
Objectiv
es 
 
Cytokine
s studied 
Assa
ys 
Improved 
Characteristi
cs 
 
Khosra
vi and 
Erle 
2016; 
USA  
 
Carvacr
ol and 
Thymol  
 
200 µM 
(equal to 
30 
µg/mL)/ 
80 µg/mL 
 
Beas-2B, 
H292 
(Mucoepider
moid 
carcinoma 
cells) and  
A549 
(Adenocarcin
omic human 
alveolar 
basal 
epithelial 
cells) 
 
To 
hypothesi
ze that 
chitin 
directly 
stimulate
s airway 
epithelial 
cells to 
release 
cytokines 
that 
promotes 
type 2 
immune 
responses  
 
IL-25 
and IL-
33  
 
ELIS
A 
 
Direct effects 
of chitin on 
airway 
epithelial cells 
are likely to 
contribute to 
allergic 
airway 
diseases like 
asthma, and 
that 
carvacrol/thy
mol directly 
inhibits 
epithelial cell 
pro-
inflammatory 
Table 1 Continued 
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responses to 
chitin 
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Table 2 In vivo studies of cytokine responses to essential oil and bioactive constituents in 
asthmatic condition 
Auth
ors, 
Year, 
Coun
try 
Substance 
 
Strai
ns/ 
Ani
mal 
Dose/ 
Route 
Objectives 
Cytok
ines 
studie
d 
Assays 
Improved 
Characterist
ics 
Bioche
mical 
Molec
ular 
 
EI 
Meza
yen et 
al; 
2006; 
Japan  
 
Thymoqu
inone  
 
BAL
B/c 
Mice 
 
 
3 mg/kg 
 (i.p.) 
 
To 
investigate  
the potential 
anti-
inflammator
y role of 
thymoquino
ne by 
examining 
its effect on 
mouse 
challenged 
through the 
airways 
with 
ovalbumin 
(OVA)  
 
IL-4, 
IL-5 
and 
IL-13 
ELISA 
 
 
Wester
n blot  
 
Thymoquino
ne has an 
anti-
inflammatory 
effect during 
the allergic 
response in 
the lung 
through the 
inhibition of 
Th2 cytokine 
mediated 
immune 
response 
 
EI 
Gazza
r et al; 
2006; 
USA
  
 
 
 
Thymoqu
inone 
 
 
BAL
B/c 
Mice  
 
3mg/kg 
 (i.p.) 
 
To examine 
the anti-
inflammator
y effect of 
thymoquino
ne in a mice 
sensitized 
and 
challenged 
with OVA 
 
IL-4, 
IL-5, 
IL-13  
and 
IL-10 
 
 
 
 
 
ELISA 
 
 
Anti-
inflammatory 
effect of 
thymoquinon
e on allergic 
lung is 
mediated  by 
a decrease in 
Th2 cytokine 
production 
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Auth
ors, 
Year, 
Coun
try 
Substance 
 
Strai
ns/ 
Ani
mal 
Dose/ 
Route 
Objectives 
Cytok
ines 
studie
d 
               Assays 
 
Biochemical         
Molecular 
Improved 
Characterist
ics 
Chang 
et al., 
2008; 
Taiwa
n 
 
5 % 
Perilla oil 
BAL
B/c 
Mice  
 
Experim
ental 
food-
oral 
To evaluate 
the anti-
inflammator
y effect of 
perilla oil 
on OVA- 
sensitized 
and 
challenged 
asthmatic 
mice 
IL-1, 
IL-2, 
IL-4, 
IL-5, 
IL-6, 
IL-10, 
Interfe
ron 
gamm
a 
(IFN-
γ) and 
TNF-α 
ELISA  Dietary 
perilla oil 
alleviates 
inflammation 
by 
decreasing 
the secretion 
of pro-
inflammatory 
cytokines in 
BALF, but 
failed to 
regulate the 
Th1/Th2 
balance 
during 
allergic 
airway 
inflammation
. 
Hirota 
et al.,  
2012; 
Japan 
 
Limonen
e isolated 
from 
Citrus 
junos  
BAL
B/c 
Mice  
4 µg 
(i.t.)  
To evaluate 
the 
inhibitory 
effect of 
limonene on 
Dermatopha
goides 
farinae-
induced 
airway 
hyper 
IFN-γ, 
IL-5, 
IL-13, 
and 
TGF-β  
ELISA   The goblet 
cell 
metaplasia, 
thickness of 
airway 
smooth 
muscle, and 
fibrosis were 
markedly 
decreased in 
limonene 
Table 2 Continued 
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responsiven
ess and 
airway 
modeling in 
a mice 
model of 
asthma 
treated mice. 
It has a 
potential to 
reduce 
airway 
remodeling 
and 
hyperrespons
iveness  
Auth
ors, 
Year, 
Coun
try 
Substance 
 
Strai
ns/ 
Ani
mal 
Dose/ 
Route 
Objectives 
Cytok
ines 
studie
d 
                  
Assays 
 
Biochemical         
Molecular 
Improved 
Characterist
ics 
Ueno-
Iio et 
al., 
2014; 
Japan 
 
Lavender 
essential 
oil 
isolated 
from 
Lavandul
a 
angustifol
ia 
BAL
B/c 
Mice  
 
 
Aerosoli
zed 5-20 
µL of 
Lvn 
To evaluate 
the anti-
inflammator
y effect of 
lavender 
essential oil 
on OVA-
induced 
bronchial 
asthma  
IL-4, 
IL-5 
and 
IL-13 
ELISA  Essential oil 
inhibits 
allergic 
inflammation 
and mucous 
cell 
hyperplasia 
with 
suppression 
of Th2 
cytokines  
 
Ku 
and 
Lin,  
2015; 
Taiwa
n 
 
Farnesol BAL
B/c 
Mice  
 
5, 25 
and 100 
mg/kg 
(mixed 
in feed) 
To 
investigate 
the effect of 
farnesol on 
OVA-
sensitized 
and 
challenged 
asthmatic 
mice  
IL-4, 
IL-5, 
IL-2, 
IFN-γ, 
IL-1β, 
TNF-α 
and 
IL-10 
ELISA  Farnesol 
supplementat
ion may be 
beneficial to 
improve the 
Th2-cytokine 
mediated 
allergic 
asthmatic 
inflammation 
Table 2 Continued 
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 Ku 
and 
Lin, 
2016; 
Taiwa
n 
 
Farnesol BAL
B/c 
Mice  
5, 25 
and 100 
mg/kg 
(mixed 
in feed) 
To 
investigate 
the effect of 
farnesol on 
allergic 
asthma by 
OVA-
sensitized 
and 
challenged 
mice 
IL-2, 
IL-4, 
IL-5 
and 
IFN-γ  
ELISA  
 
 
 
 
 
 
 
 
 
Farnesol 
improved 
allergic 
antibody 
levels and 
regulated Th2 
responses towards 
Th1 immune balance 
and ameliorate 
inflammation  
 
Auth
ors, 
Year, 
Coun
try 
Substance 
 
Strai
ns/ 
Ani
mal 
Dose/ 
Route 
Objectives 
Cytok
ines 
studie
d 
                  
Assays 
 
Biochemical         
Molecular 
 
Improved 
Characterist
ics 
Kian
mehr 
et al., 
2017; 
Iran  
Thymol 
from 
Zataria 
multiflora 
BAL
B/c 
Mice  
200, 400 
and 800 
µg/mL 
(p.o.) 
To 
investigate 
the effect of 
Z. multiflora 
containing 
thymol on 
cytokine 
genes 
expression 
on OVA-
injected 
experimenta
l mouse 
model of 
asthma 
IFN-γ, 
IL-4, 
TGF-β 
and 
IL-17 
 Real 
time-
PCR 
Z. multiflora 
containing 
thymol 
decreased 
pro 
inflammatory 
cytokines but 
increased 
anti-
inflammatory 
cytokines 
gene 
expression 
and the 
number of 
Treg in 
splenocytes 
of asthmatic 
mice 
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Pina 
et al., 
2018; 
Brazil   
 
Citronell
ol, α-
terpineol 
and 
carvacrol   
 
Swis
s 
Mice 
 
 
25, 50 
or 100 
mg/kg 
(i.p.) 
 
Effects of 
citronellol, 
α-terpineol 
and 
carvacrol on 
allergic 
airway 
inflammatio
n 
established 
by OVA 
 
TNF-α 
ELISA 
 
 
 
 
 
 
 
 
 
 
 
Monoterpene
s decreased 
leucocyte 
migration 
and TNF-α 
levels, it can 
be an 
alternative 
for treatment 
of allergic 
airway 
inflammation  
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